Business Practice

To see continued progress, the pharma and tech industries must collaborate.

How will bureaucratic red tape affect pharma’ ability to support women seeking abortions?

What role must pharma play to help improve outcomes for women?

How can companies realistically incorporate patient-centric practices into cell and gene product development?

Five members of The Medicine Maker’s 2022 Power List share their thoughts on how the pharma industry can improve.

As the ATMP hiring market struggles through the Great Resignation, can VR take us back to the future?

AI is making waves across industries, but what impact will it have on pharmaceutical marketing?

Why pharma and the high tech sector should band together for the sake of innovation.

Change is in the air for drug pricing in the US after the Senate passes the Inflation Reduction Act.

Ashfield Engage’s Ian Riches explains how companies can make patient engagement a priority.